The global healthcare industry is in dire need of reliable and early detection methods for cancer, particularly lung cancer, which has a high mortality rate due to late diagnosis. Our biosensor addresses this critical need by offering a quantum-enhanced solution that can detect biomarkers at much lower concentrations, enabling earlier diagnosis and treatment. By bridging the gap between quantum technology and practical healthcare applications, QUANTFOCUS LABS Private Ltd aims to make a significant impact on global health outcomes.